Skip to content

Topics: Health, Health Care, Pharmaceuticals

  • Uppsala Health Summit publishes pre-conference report

    For the upcoming Uppsala Health Summit on antibiotic resistance, 2–3 June, a report has now been published focusing on some of the most pressing issues and challenges. The aim of the meeting is to move the discussion forward, from the ‘what’ to the ‘who’ and ‘how’.

  • New biomarker for uterine cancer discovered

    Researchers at Uppsala University have, together with researchers from Turku and Bergen, discovered a new biomarker which makes it possible to identify women with uterine cancer who have a high risk of recurrence. The findings were recently published in the journal Gynecologic Oncology.

  • Uppsala Health Summit on Antibiotic Resistance to follow decision by WHO

    Shortly after the World Health Organization (WHO) global action plan on antibiotic resistance has been adopted in May 2015, researchers, politicians and representatives from public health organizations and the pharmaceutical industry will gather in Uppsala, Sweden, to discuss the most urgent next steps.

  • Antibiotic resistance on the agenda in Uppsala, Sweden and worldwide

    The theme for the next Uppsala Health Summit, to be held in Uppsala, Sweden, on 2–3 June 2015, is antibiotic resistance — one of the biggest global health challenges of our day. The basis of the Summit will be the WHO draft Global Action Plan against antimicrobial resistance that is the focus for the high-level meeting starting today in Stockholm, hosted by the Public Health Agency of Sweden.

  • New method to determine antibiotic resistance fast

    ​Scientists from Uppsala University, the Science for Life Laboratory (SciLifeLab) in Stockholm and Uppsala University Hospital have developed a new method of rapidly identifying which bacteria are causing an infection and determining whether they are resistant or sensitive to antibiotics. The findings are now being published in the Journal of Clinical Microbiology.

  • New classification improves risk prediction in chronic lymphocytic leukemia

    If chronic lymphocytic leukemia patients with a good or poor prognosis could be identified already at the time of diagnosis, physicians would have better possibilities to adjust their therapeutic and follow-up strategies. Now researchers at Uppsala University have discovered a new correlation between specific molecular features of the disease and subgroups of patients with different prognosis.

  • New findings show that different brain tumours have the same origin

    Different types of glioma are usually diagnosed as separate diseases and have been considered to arise from different cell types in the brain. Now researchers at Uppsala University have shown that one and the same cell of origin can give rise to different types of glioma.

  • Brain simulation raises questions

    What does it mean to simulate the human brain? Why is it important to do so? And is it even possible to simulate the brain separately from the body it exists in? These questions are discussed in a new paper published in the scientific journal Neuron today.

  • New report: Lifestyle changes and new technology can ease elders’ lives

    If we embrace lifestyle changes and new technology, we improve our prospects of staying healthy in old age, getting good care and reducing our dependence on others. This is the message of a new report summarising the conclusions from the conference Uppsala Health Summit in June.

  • Lack of sleep increases risk of failure in school

    A new Swedish study shows that adolescents who suffer from sleep disturbance or habitual short sleep duration are less likely to succeed academically compared to those who enjoy a good night’s sleep. The results have recently been published in the journal Sleep Medicine.

  • Genetics and lifestyle have a strong impact on biomarkers for inflammation and cancer

    In a new study published in Nature Communications, research scientists from Uppsala University present for the first time a large-scale study of the significance of genetic, clinical and lifestyle factors for protein levels in the bloodstream. The results of the study show that genetics and lifestyle are determining factors for protein levels.

  • Supermaterial gives rejected drugs a new chance

    More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new material Upsalite®, has great potential for development of new formulations of these rejected drugs.

  • Obesity Gene Linked to Hormonal Changes that Favor Energy Surplus

    A new study from Uppsala University demonstrates that elderly humans carrying a common variant of the fat mass and obesity gene FTO also have a shifted endocrine balance. Low blood concentrations of the satiety hormone leptin and high blood concentrations of the hunger promoting hormone ghrelin makes carriers of the FTO gene put on weight. The findings are published in the journal Diabetes.

  • PCB increases harmful effects of smoking

    In a new study published today in the journal Plos One, researchers at Uppsala University show that the harmful effect of smoking is aggravated if the person has high blood levels of PCB. This indicates that environmental contaminants interact with other risk factors for various diseases – a field the researchers claim is under-researched.

  • Press invitation: Uppsala Health Summit seeking smart solutions in ageing society

    Get set for 3-4 June: Uppsala University and seven other Swedish actors, has invited politicians, opinion-makers and experts from healthcare, academia and companies to an unconditional and open dialogue on the ways forward in an ageing society. The goal of the Uppsala Health Summit is to move from knowledge to action.

  • €85million European programme targets novel antibiotics

    The growing problem of resistance to antibiotics is very costly, both in human lives and in resources. Uppsala University is now to be a leading actor in a gigantic EU-funded project in which academia, the pharmaceutical industry and the biotechnology industry will collaborate to fast-track the development of new antibiotics.

  • Sleep to protect your brain

    A new study from Uppsala University, Sweden, shows that one night of sleep deprivation increases morning blood concentrations of NSE and S-100B in healthy young men. These molecules are typically found in the brain. Thus, their rise in blood after sleep loss may indicate that a lack of snoozing might be conducive to a loss of brain tissue. The findings are published in the journal SLEEP.

Show more